GlassScriptPhysician profile
Salim Hosein
NPI 1639427933
$11,860.22
in general payments reported to CMS, 2019-2025
12 companies · $4,630 in 2025
The $4,630 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2021: $323 · 2022: $369 · 2023: $2,550 · 2024: $2,414 · 2025: $4,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,182 · Travel and Lodging: $3,305 · Food and Beverage: $1,091 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,182.27 |
| Travel and Lodging | $3,304.67 |
| Food and Beverage | $1,090.66 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,051.72 | 2022-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,449.06 | 2019 | |
| Medtronic, INC. | $334.53 | 2021-2024 | Signia |
| Ethicon US, LLC | $249.31 | 2024-2025 | Linx Reflux Management System, Echelon Endopath, Harmonic |
| Boston Scientific Corporation | $236.98 | 2021-2025 | Apollo Esg Nxt System |
| Novo Nordisk INC | $171.55 | 2023-2025 | Wegovy |
| Baxter Healthcare | $110.04 | 2022 | |
| Allergan, INC. | $98.88 | 2022 | |
| Davol INC. | $95.92 | 2019 | |
| Stryker Corporation | $29.69 | 2019 | |
| Tela Bio, INC. | $19.94 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Teleflex LLC | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salim Hosein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.